6.48
-0.09(-1.37%)
Currency In USD
| Previous Close | 6.57 |
| Open | 6.62 |
| Day High | 6.67 |
| Day Low | 6.33 |
| 52-Week High | 11.78 |
| 52-Week Low | 3.72 |
| Volume | 21,489 |
| Average Volume | 135,159 |
| Market Cap | 72.28M |
| PE | -7.2 |
| EPS | -0.9 |
| Moving Average 50 Days | 7.78 |
| Moving Average 200 Days | 6.29 |
| Change | -0.09 |
If you invested $1000 in Nutriband Inc. (NTRB) since IPO date, it would be worth $1,128.92 as of August 18, 2025 at a share price of $6.48. Whereas If you bought $1000 worth of Nutriband Inc. (NTRB) shares 3 years ago, it would be worth $1,375.8 as of August 18, 2025 at a share price of $6.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
GlobeNewswire Inc.
6 hours ago
Nutriband Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth ConferenceORLANDO, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (Nasd
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
GlobeNewswire Inc.
Aug 11, 2025 9:00 AM GMT
Sheridan will temporarily step aside as CEO to enter the Irish Presidential Election. Company Chairman and President, Serguei Melnik will take over as interim CEO over the course of the campaign and election period. ORLANDO, Fla., Aug. 11, 2025 (G
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
GlobeNewswire Inc.
Aug 08, 2025 12:00 PM GMT
FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization. Nutriband is partnering with Kindeva to develop AVERSA™ FE